Le marché de l'analyse unicellulaire devrait passer de 3,18 milliards de dollars américains en 2021 à 8,20 milliards de dollars américains d'ici 2028 ; il devrait croître à un TCAC de 14,5 % entre 2022 et 2028.
L'analyse unicellulaire permet une analyse approfondie de la différenciation des cellules souches, du cancer et des fonctions physiologiques des embryons. et les adultes. Des technologies avancées telles que les technologies de séquençage unicellulaire, l'hybridation in situ, la détection basée sur la fluorescence et la spectroscopie de masse peuvent être utilisées pour étudier les maladies et le développement de médicaments, grâce à quoi le marché de l'analyse unicellulaire devrait connaître une croissance exponentielle. p>
DYNAMIQUE DU MARCHÉ
La croissance du marché de l'analyse unicellulaire est principalement attribuée à l'augmentation de la R&D dans les industries pharmaceutique et biotechnologique, à l'augmentation du nombre de cas de cancer, aux technologies progrès et demande croissante de médecine personnalisée. De plus, les progrès rapides dans la recherche sur le cancer et la collaboration stratégique entre les principaux acteurs devraient alimenter le marché de l’analyse unicellulaire au cours de la période de prévision. Cependant, les coûts élevés et la pénurie de professionnels qualifiés sont des facteurs qui entravent la croissance du marché.
ÉTENDUE DU MARCHÉ
L'analyse globale d'une cellule unique Analyse du marché jusqu’en 2028» Le rapport vise à fournir un aperçu du marché avec une segmentation détaillée basée sur le produit, le type de cellule, la technique, l’application et l’utilisateur final. Le rapport fournit des statistiques clés du marché basées sur les performances des principaux acteurs. Il présente également des tendances et des opportunités clés sur le marché.
Aperçus stratégiques
SEGMENTATION DU MARCHÉ
Le marché mondial de l’analyse unicellulaire est segmenté en produit, type de cellule, technique, application et utilisateur final. En fonction du produit, le marché est divisé en consommables et instruments. Par type de cellule, le marché est segmenté en cellules humaines, cellules animales et cellules microbiennes. En termes de technique, le marché est classé en cytométrie en flux, séquençage de nouvelle génération, réaction en chaîne par polymérase, microscopie, spectrométrie de masse et autres techniques. Du point de vue des applications, le marché est divisé en applications de recherche et applications médicales. Le segment des utilisateurs finaux est ensuite segmenté en laboratoires universitaires et de recherche, sociétés de biotechnologie et pharmaceutiques, hôpitaux et laboratoires de diagnostic, ainsi que banques de cellules et centres de FIV.
CADRE RÉGIONAL
Le marché mondial de l'analyse unicellulaire est segmenté en cinq grandes régions : Amérique du Nord, Europe, Asie-Pacifique, Moyen-Orient et Amérique du Nord. Afrique et Afrique du Sud et Amérique centrale. Le rapport couvre l'analyse et les prévisions de 18 pays ainsi que les tendances et opportunités prévalant dans la région.
D'un point de vue régional, l'Amérique du Nord a dominé le marché de l'analyse unicellulaire avec environ 42 % de part de marché en 2021. La croissance du marché dans la région est principalement attribuée à l’augmentation des dépenses de R&D et du financement gouvernemental, à la croissance de l’industrie pharmaceutique et des sciences de la vie, aux initiatives stratégiques d’acteurs de premier plan ainsi qu’à l’existence d’acteurs majeurs dans la région. Par exemple, en janvier 2022, Amgen a conclu un partenariat avec Generate Biomedicines pour découvrir et créer des thérapies protéiques pour cinq cibles dans divers domaines thérapeutiques et de multiples fonctionnalités avec un investissement d'un milliard de dollars. De plus, l’incidence élevée de maladies chroniques telles que les cancers dans la région stimule la croissance du marché. La figure ci-dessous présente la tendance à la croissance des revenus sur le marché mondial de l'analyse unicellulaire :
Source : The Insight Partners Analysis< /em>
Le rapport analyse les facteurs, tels que les moteurs, les contraintes, les opportunités et les tendances futures, affectant le marché de l’analyse unicellulaire. Il fournit également une analyse exhaustive des cinq forces de Porter du marché de l'analyse unicellulaire.
IMPACT DE LA PANDÉMIE DE COVID-19
L'analyse unicellulaire aide dans l'interprétation de la réponse immunitaire périphérique à l'infection par la COVID-19 et contribue à de nouvelles approches de recherche sur les mécanismes de la maladie et les options de traitement, ce qui entraîne l'adoption accrue de produits d'analyse unicellulaire pour la recherche sur la COVID-19. Par conséquent, la demande accrue de produits et les activités de recherche en cours devraient créer des opportunités de croissance du marché. Bien que diverses décisions gouvernementales dues aux conditions économiques pandémiques aient limité la production globale, les produits d’analyse unicellulaire ont connu une demande croissante pour le développement et la production de vaccins à travers le monde. Ainsi, le marché de l'analyse unicellulaire a été impacté positivement pendant la pandémie de COVID-19.
ACTEURS DU MARCHÉ
Le rapport couvre les développements clés dans le secteur de l'analyse unicellulaire. marché de l'analyse. Diverses entreprises se concentrent sur des stratégies de croissance organique, telles que les lancements de produits, les approbations de produits, les brevets et les événements. Les stratégies de croissance inorganique telles que les acquisitions, les partenariats et les collaborations ont encouragé l’expansion des activités et de la clientèle des acteurs du marché. Les acteurs du marché opérant sur le marché de l’analyse unicellulaire devraient connaître des opportunités de croissance lucratives dans les années à venir avec la demande croissante de produits d’analyse unicellulaire.
Le rapport comprend également les profils des principaux acteurs du marché de l’analyse unicellulaire. sociétés du marché de l’analyse cellulaire, ainsi que leur analyse SWOT et leurs stratégies de marché. En outre, le rapport se concentre sur les principaux acteurs du secteur avec des informations telles que les profils d’entreprise, les composants et services proposés, les informations financières des trois dernières années et les développements clés des cinq dernières années. La liste de quelques entreprises engagées sur le marché de l'analyse unicellulaire est mentionnée ci-dessous :
- Agilent Technologies
- Beckman Coulter Inc.
- Becton Dickinson & Entreprise (BD)
- Bio-Rad Laboratories, Inc.
- Fluidigm Corporation
- GE Healthcare
- Illumina, Inc.
- Merck KGaA
- Qiagen NV
- Thermo Fisher Scientific, Inc.
L'équipe de recherche et d'analyse dédiée d'Insight Partner est composée de professionnels expérimentés dotés d'une expertise statistique avancée et propose diverses options de personnalisation dans l'étude existante.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. Agilent Technologies
2. Beckman Coulter Inc.
3. Becton Dickinson & Company (BD)
4. Bio-Rad Laboratories, Inc.
5. Fluidigm Corporation
6. GE Healthcare
7. Illumina, Inc.
8. Merck KGaA
9. Qiagen N.V.
10. Thermo Fisher Scientific, Inc.
11. Danaher Corporation
12. Merck Millipore
13. 10x Genomics
14. Promega Corporation
15. NanoString Technologies
16. Tecan Group
17. Sartorius AG
18. Luminex Corporation
19. Takara Bio
20. Fluxion Biosciences
21. Menarini Silicon Biosystems
22. LumaCyte
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2024
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2024
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2024
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2024
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)